simvastatin and Muscle Weakness

Topics: Animals; Ataxia; Cell Line; Cell Survival; Heart Failure; Humans; Mice; Mitochondria; Mitochondrial Diseases; Muscle Fibers, Skeletal; Muscle Weakness; Muscular Diseases; Nanocomposites; Oxygen Consumption; Simvastatin; Ubiquinone

Topics: Animals; Exercise Therapy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Muscle Weakness; Muscle, Skeletal; Simvastatin; Trimetazidine; Vasodilator Agents

Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People

Topics: Acetyl-CoA C-Acetyltransferase; Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; CCAAT-Binding Factor; Chronic Disease; Extracellular Matrix Proteins; Fibrosis; Gene Expression; Inflammation; Male; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Weakness; Myosin Heavy Chains; PPAR gamma; Rats; Rats, Sprague-Dawley; Regeneration; Rotator Cuff; Rotator Cuff Injuries; Rupture; Shoulder Pain; Simvastatin

Topics: Aged; Anticholesteremic Agents; Atorvastatin; Case-Control Studies; Humans; Insulin Resistance; Male; Muscle Contraction; Muscle Proteins; Muscle Strength; Muscle Weakness; Reaction Time; RNA, Messenger; Simvastatin

Topics: Aged; Autoantibodies; Azathioprine; Biopsy; Bulbar Palsy, Progressive; Edema; Glucocorticoids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Male; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Necrosis; Prednisolone; Recovery of Function; Simvastatin; Treatment Outcome

Topics: Aged; Biopsy; Creatine Kinase; Cytoplasm; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inclusion Bodies; Male; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Necrosis; Pain; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Simvastatin; Sulfonamides

Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Contraindications; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iatrogenic Disease; Muscle Weakness; Muscle, Skeletal; Rhabdomyolysis; Risk Factors; Simvastatin

Topics: Alcoholism; Electromyography; Electrophysiology; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Interferons; Male; Microscopy, Electron; Middle Aged; Muscle Weakness; Muscle, Skeletal; Myositis, Inclusion Body; Simvastatin

Topics: Aged, 80 and over; Anti-Bacterial Agents; Anticholesteremic Agents; Clarithromycin; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Female; Humans; Muscle Weakness; Pain; Rhabdomyolysis; Simvastatin

Topics: Anticholesteremic Agents; Azetidines; Cholinesterase Inhibitors; Electromyography; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Middle Aged; Muscle Weakness; Myasthenia Gravis; Simvastatin; Treatment Outcome

Topics: Aged; Diabetes Complications; Diagnosis, Differential; Electromyography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileus; Leg; Male; Muscle Weakness; Muscular Diseases; Pain; Physical Examination; Quadriceps Muscle; Radiography, Abdominal; Rhabdomyolysis; Simvastatin

Topics: Adult; Aged; Atorvastatin; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Motor Activity; Muscle Cramp; Muscle Weakness; Muscle, Skeletal; Musculoskeletal Diseases; Pain; Pyrimidines; Pyrroles; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Surveys and Questionnaires; Treatment Outcome

Topics: Aged; Anticholesteremic Agents; Humans; Male; Muscle Weakness; Pain; Pain Management; Rhabdomyolysis; Simvastatin

Topics: Adult; Creatine Kinase; Female; Humans; Male; Muscle Cramp; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Norway; Simvastatin

Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Atorvastatin; Creatine Kinase; Female; Folic Acid Antagonists; Genes, MHC Class I; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Male; Methotrexate; Middle Aged; Mitochondria, Muscle; Muscle Weakness; Muscular Diseases; Prednisolone; Pyrroles; Sarcolemma; Simvastatin; Up-Regulation

Topics: Calcinosis; Deglutition Disorders; Dysarthria; Dyspnea; Fatal Outcome; Fibrosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Muscle Fibers, Skeletal; Muscle Weakness; Muscular Diseases; Necrosis; Simvastatin

Topics: Diagnosis, Differential; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Simvastatin; Vitamin D Deficiency

Topics: Acute Disease; Aged; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leg; Male; Muscle Weakness; Rhabdomyolysis; Simvastatin

Topics: Calcium Channel Blockers; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Weakness; Muscles; Simvastatin; Verapamil